To our knowledge, this is the first time to propose that METTL3 and METTL14 play opposite roles in lung cancer cells and tumor stromal cells, precisely explaining why high levels of m6A  methylation  can be predictive of better prognosis in NSCLC patients. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.